TLSI
TLSI
NASDAQ · Biotechnology

Trisalus Life Sciences Inc

Penny Stocks Biotech Stocks Healthcare Stocks
$4.43
-0.03 (-0.67%)
As of May 16, 2:04 AM ET ·
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Buy 10 91%
Hold 1 9%
Sell 0 0%
Price Target
Analyst Price Target -2.3% upside
Low Target $2.61
Average Target $4.33
High Target $5.56
Current Price $4.43
Current
$4.43
Target
$4.33
$2.61 $4.33 avg $5.56
Scenario Analysis
Bear Case
$2.61
-41.1%
Low target
Base Case
$4.33
-2.3%
Avg target
Bull Case
$5.56
+25.5%
High target
Risk/Reward
0.6x
Unfavorable
Price in Context
52-Week High
$7.95
-44.3% from high
52-Week Low
$2.20
+101.4% from low
Target vs 52W High
$4.33
-45.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +22.4%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -41.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +179.9%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +0.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.0%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -64.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -21.7%
BIIB
Biogen Inc
 Buy 43 56% $91.45 -52.6%